These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 13710262)

  • 41. [Cortisone drugs in therapy of myocardial infarct; preliminary note].
    BERTOLA A; CATELLI P
    Boll Soc Med Chir Cremona; 1957; 12(1):59-63. PubMed ID: 13510489
    [No Abstract]   [Full Text] [Related]  

  • 42. [Value of butazolidine in therapy of myocardial infarct; preliminary note on 18 cases].
    MATHIEU L; PERNOT C; METZ J; ARMAND P; STREIFF F; ROBERT J
    Rev Med Nancy; 1959 Feb; 84():168-76. PubMed ID: 13634755
    [No Abstract]   [Full Text] [Related]  

  • 43. Combination of electrocardiographic and angiographic markers of reperfusion in the prediction of infarct size in patients with ST-segment elevation myocardial infarction undergoing successful primary angioplasty.
    De Luca G; Suryapranata H; de Boer MJ; Ottervanger JP; Hoorntje JC; Gosselink AT; Dambrink JH; Ernst N; van 't Hof AW;
    Int J Cardiol; 2007 Apr; 117(2):232-7. PubMed ID: 16899313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study).
    Ly HQ; Denault A; Dupuis J; Vadeboncoeur A; Harel F; Arsenault A; Gibson CM; Bonan R
    Am Heart J; 2005 Nov; 150(5):933. PubMed ID: 16290966
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized evaluation of the effects of filter-based distal protection on myocardial perfusion and infarct size after primary percutaneous catheter intervention in myocardial infarction with and without ST-segment elevation.
    Gick M; Jander N; Bestehorn HP; Kienzle RP; Ferenc M; Werner K; Comberg T; Peitz K; Zohlnhöfer D; Bassignana V; Buettner HJ; Neumann FJ
    Circulation; 2005 Sep; 112(10):1462-9. PubMed ID: 16129793
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Angiogenic growth factors and/or cellular therapy for myocardial regeneration: a comparative study.
    Chachques JC; Duarte F; Cattadori B; Shafy A; Lila N; Chatellier G; Fabiani JN; Carpentier AF
    J Thorac Cardiovasc Surg; 2004 Aug; 128(2):245-53. PubMed ID: 15282461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Predictive value of Q waves on the 12-lead electrocardiogram after reperfusion therapy for ST elevation myocardial infarction.
    van der Vleuten PA; Vogelzang M; Svilaas T; van der Horst IC; Tio RA; Zijlstra F
    J Electrocardiol; 2009; 42(4):310-8. PubMed ID: 19362318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The future of cell therapy for acute myocardial infarction.
    Caplice NM
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S129-32. PubMed ID: 16501619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction.
    Ganame J; Messalli G; Dymarkowski S; Rademakers FE; Desmet W; Van de Werf F; Bogaert J
    Eur Heart J; 2009 Jun; 30(12):1440-9. PubMed ID: 19346229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Myocardial infarction 2009--Randomized studies vs. clinical daily routine].
    Zeymer U; Zahn R; Gitt A; Schneider S; Senges J
    Dtsch Med Wochenschr; 2009 Oct; 134 Suppl 6():S190-1. PubMed ID: 19834837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Estimation of infarct size by single measurements of creatine kinase levels in patients with a first myocardial infarction.
    Di Chiara A; Plewka M; Werren M; Badano LP; Fresco C; Fioretti PM
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):340-6. PubMed ID: 16645412
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Long-term prognosis in patients with acute myocardial infarct and treatment with direct coronary angioplasty].
    Simek S; Aschermann M; Holm F; Humhal J; Linhart A; Psenicka M; Golán L; Mrázek V
    Cas Lek Cesk; 2003 Aug; 142(8):487-92. PubMed ID: 14626565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Optimizing systems of care for patients with acute myocardial infarction. STEMI networks, telemetry ECG, and standardized quality improvement with systematic data feedback].
    Scholz KH; von Knobelsdorff G; Ahlersmann D; Keating FK; Jung J; Werner GS; Nitsche R; Duwald H; Hilgers R
    Herz; 2008 Mar; 33(2):102-9. PubMed ID: 18344028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.
    Lutz M; Rosenberg M; Kiessling F; Eckstein V; Heger T; Krebs J; Ho AD; Katus HA; Frey N
    Cardiovasc Res; 2008 Jan; 77(1):143-50. PubMed ID: 18006465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial).
    Marso SP; Miller T; Rutherford BD; Gibbons RJ; Qureshi M; Kalynych A; Turco M; Schultheiss HP; Mehran R; Krucoff MW; Lansky AJ; Stone GW
    Am J Cardiol; 2007 Jul; 100(2):206-10. PubMed ID: 17631071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained benefit 20 years after reperfusion therapy in acute myocardial infarction.
    van Domburg RT; Sonnenschein K; Nieuwlaat R; Kamp O; Storm CJ; Bax JJ; Simoons ML
    J Am Coll Cardiol; 2005 Jul; 46(1):15-20. PubMed ID: 15992629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Shifting from pharmacological to systematic mechanical reperfusion therapy for acute myocardial infarction via a cooperating network: impact on reperfusion rate and in-hospital mortality.
    Falsini G; Liistro F; Ducci K; Angioli P; Baldassarre S; Sabini A; Burali A; Bolognese L
    J Cardiovasc Med (Hagerstown); 2008 Mar; 9(3):245-50. PubMed ID: 18301140
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Management of acute myocardial infarction--primary angioplasty the treatment of choice!
    Kaul U; Gupta RK
    J Assoc Physicians India; 2004 Dec; 52():986-9. PubMed ID: 15884459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.